{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:33:04Z","timestamp":1758043984813,"version":"3.44.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11096-025-01970-8","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T15:17:59Z","timestamp":1754579879000},"page":"1544-1545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Idiopathic fascicular ventricular tachycardia and verapamil: how to administer a continuous perfusion"],"prefix":"10.1007","volume":"47","author":[{"given":"Alma","family":"Feka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Perrottet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshid","family":"Sadeghipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"issue":"40","key":"1970_CR1","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997\u20134126.","journal-title":"Eur Heart J"},{"key":"1970_CR2","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0002-9149(84)80133-2","volume":"54","author":"AE Buxton","year":"1984","unstructured":"Buxton AE, Marchlinski FE, Doherty JU, et al. Repetitive, monomorphic ventricular tachycardia: clinical and electrophysiologic characteristics in patients with and patients without organic heart disease. Am J Cardiol. 1984;54:997\u20131002.","journal-title":"Am J Cardiol"},{"key":"1970_CR3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0002-9149(94)90877-X","volume":"73","author":"MJ Griffith","year":"1994","unstructured":"Griffith MJ, Garratt CJ, Rowland E, et al. Effects of intravenous adenosine on verapamil-sensitive \u2018idiopathic\u2019 ventricular tachycardia. Am J Cardiol. 1994;73:759\u201364.","journal-title":"Am J Cardiol"},{"issue":"8","key":"1970_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/archdischild-2018-315617","volume":"104","author":"J Kehr","year":"2019","unstructured":"Kehr J, Binfield A, Maxwell F, et al. Fascicular tachycardia in infancy and the use of verapamil: a case series and literature review. Arch Dis Child. 2019;104(8):789\u201392.","journal-title":"Arch Dis Child"},{"key":"1970_CR5","unstructured":"Sandoz. Product monograph, including patient medication information (verapamil hydrochloride injection USP) 2022. https:\/\/pdf.hres.ca\/dpd_pm\/00066847.PDF. Accessed 5 May 2025."},{"key":"1970_CR6","unstructured":"Mylan. Package leaflet: Information for the user (Verapamil 2.5 mg\/ml Solution for injection) https:\/\/www.medicines.org.uk\/emc\/files\/pil.979.pdf. Accessed 5 May 2025."},{"key":"1970_CR7","unstructured":"Exela Pharma Sciences. Verapamil hydrochloride injection 2017. https:\/\/www.fffenterprises.com\/assets\/downloads\/product-information\/exela\/pi-VERAPAMIL.pdf. Accessed 5 May 2025."},{"key":"1970_CR8","unstructured":"Viatris. Isoptin Injektionsl\u00f6sung [Isoptin solution for injection] 2022. https:\/\/www.fachinfo.de\/fi\/pdf\/007603. Accessed 5 May 2025."},{"key":"1970_CR9","unstructured":"Viatris. Australian product information: Isoptin (verapamil hydrochloride injection solution) 2023. https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent=&id=CP-2010-PI-04267-3&d=20250501172310101. Accessed 5 May 2025."},{"key":"1970_CR10","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Examen du dossier des sp\u00e9cialit\u00e9s inscrites pour une dur\u00e9e limit\u00e9e conform\u00e9ment au d\u00e9cret du 27 octobre 1999 (JO du 30 octobre 1999) et \u00e0 l\u2019arr\u00eat\u00e9 du 1er d\u00e9cembre 2006 (JO du 21 d\u00e9cembre 2006): Isoptine [Examination of the dossier of proprietary medicinal products registered for a limited period in accordance with the decree of 27 October 1999 (JO of 30 October 1999) and the order of 1 December 2006 (JO of 21 December 2006): Isoptine] 2007. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/ct-4944_isoptine.pdf. Accessed 5 May 2025."},{"key":"1970_CR11","unstructured":"Centrafarm. Summary of product characteristics (Verapamil HCl CF 2,5 mg\/ml, oplossing voor injectie) [Verapamil HCl CF 2.5 mg\/ml, solution for injection] 2022. https:\/\/www.geneesmiddeleninformatiebank.nl\/smpc\/h56335_smpc.pdf. Accessed 5 May 2025."}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-01970-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T08:30:48Z","timestamp":1757665848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-01970-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-01970-8","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"type":"print","value":"2210-7703"},{"type":"electronic","value":"2210-7711"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No ethics approval was needed for this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}